GLTO - Galecto Inc Profit before interest, taxes and amortization

Brandmark of Galecto (GLTO)

Galecto, Inc. (GLTO) struggle to regain shareholder confidence following failed trials is evidenced by volatility: changes in EBITDA_Co demonstrate high sensitivity to shocks, where the current parameter equals 0.00. Stability is provided by multi-billion dollar investments in R&D for galectin inhibitors. These developments aim to curb tissue scarring in the liver and lungs, preventing irreversible organ degradation.

Galecto Corp - GLTO Operating profit EBITDA (period 11/23/2025 - 03/10/2026)

Summary analytical data breakdowns for Galecto (GLTO)

- current quotes and average value forecast:
Stock Quotes Galecto Corporation|GLTO - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Galecto|GLTO - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Galecto|GLTO - Book Capitalization|Market Capitalization to Book Value Ratio galecto.com|GLTO - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity Galecto, Inc.|GLTO - Long-Term Debt to Equity|Current Liabilities to Capital Galecto Inc|GLTO - Company Debts|Debt to Book Capitalization Ratio Galecto|GLTO - Company Long-Term Debts|Short-Term Debt Volume Galecto|Interim Coverage Ratio galecto.com
- financial results and valuation multiples details:
GLTO - Company Net Income|Future Profit Galecto, Inc.|GLTO - P/E Multiple|Forward Price to Earnings Multiple galecto.com|GLTO - PEG Multiple|EV/EBITDA Multiple Galecto|GLTO - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Galecto|GLTO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months galecto.com|GLTO - Earnings growth in current year|Expected earnings per share growth for next year Galecto, Inc.
Analysis of all company metrics:Galecto Corporation (GLTO)
Manufactured products of Galecto, Inc.

For Galecto, Inc., which is developing a diversified portfolio of anti-fibrotic drugs, the scale of operations is determined by the ability to fund multi-profile research. This metric measures net cash flow from operating activities before interest and taxes, allowing the investor to strip away accounting adjustments and assess the real solvency of the business through the history of operating profit in cash.

Who Galecto, Inc. competes with

ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Corp) - Operating profit EBITDA|Operating profit EBITDA MoonLake Corp|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (newamsterdampharma.com)|Profit before payment of interest, taxes and amortization Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Profit before interest, taxes and amortization|ETNB - Profit before payment of interest, taxes and amortization|AGIO: Profit before payment of interest, taxes and amortization|GPCR: Operating profit EBITDA|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute|Lexicon Pharmaceuticals Inc (LXRX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization MBX Bio (MBX)|Operating profit before deduction of amortization Altimmune Pharma ALT|Operating profit EBITDA AARD (Aardvark Therapeutics Inc)|Operating profit before depreciation charges sagimet.com|BioAge - Operating profit EBITDA|BMEA - Operating profit EBITDA|quincetx.com (QNCX) - Profit before payment of interest, taxes and amortization|GUTS (Fractyl Health, Inc) - Profit before payment of interest, taxes and amortization|VTVT (vTv Therapeutics, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Agape ATP Corp. ATPC|Operating profit EBITDA PLUR|Operating profit before deduction of amortization synlogictx.com SYBX|Lipocine Corp - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization MTNB (Matinas BioPharma Holdings, Inc.)|SPRB - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization carmellrx.com|LUMO (Lumos Pharma) - Operating profit before deduction of amortization|Organovo Holdings - Income before deduction of interest, taxes and amortization|RDUS (Radius Health) - Operating profit EBITDA